ctrl K

Advertisement

Lipella Pharmaceuticals I... (LIPO)

NASDAQ: LIPO · Real-Time Price · USD

2.50

-0.13 (-5.12%)

At close: Apr 29, 2025, 3:43 PM

Lipella Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	536.36K	449.62K	184.16K	259.35K	961.68K	694.75K
Cost of Revenue	3.61M	3.04M	2.55M	1.46M	975.96K	682.89K
Gross Profit	-3.08M	-2.59M	-2.36M	-1.2M	-14.28K	11.86K
Operating Income	-5.08M	-4.75M	-2.59M	-1.92M	-56.86K	-53.79K
Interest Income	64.28K	137.84K	1.68K	104.00	3.17K	334.00
Pretax Income	-5.02M	-4.62M	-2.6M	-1.87M	-61.66K	-61.85K
Net Income	-5.02M	-4.62M	-2.6M	-1.87M	-66.45K	-61.85K
Selling & General & Admin	2M	2.16M	226.19K	718.38K	42.59K	65.65K
Research & Development	n/a	3.04M	2.55M	1.46M	975.96K	682.89K
Other Expenses	n/a	n/a	-45	57.09K	n/a	n/a
Operating Expenses	2M	2.16M	2.77M	2.18M	1.02M	748.54K
Interest Expense	n/a	10.85K	9.61K	6.83K	7.96K	8.39K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	5.62M	5.2M	2.77M	2.18M	1.02M	748.54K
Income Tax Expense	n/a	n/a	-1.63K	6.73K	4.79K	-53.79K
Shares Outstanding (Basic)	1.05M	749.83K	507.36K	423.97K	266.4K	260K
Shares Outstanding (Diluted)	1.05M	750.38K	507.58K	426.01K	266.4K	260K
EPS (Basic)	-4.79	-6.16	-5.12	-4.38	-0.23	-0.24
EPS (Diluted)	-4.79	-6.16	-5.12	-4.4	-0.23	-0.24
EBITDA	-5.01M	-4.61M	-2.59M	n/a	-53.69K	334.00
EBIT	-5.02M	-4.61M	-2.59M	-1.86M	-53.69K	-53.46K
Depreciation & Amortization	2.89K	1.69K	2.59M	1.92M	56.86K	53.79K